Should clot composition affect choice of endovascular therapy?
Abstract
Endovascular therapy has become a promising alternative for patients who are ineligible for IV thrombolysis or for whom it has failed. Greater knowledge about the composition of thromboembolic material underlying the vascular occlusion in stroke patients may provide the means for improving existing endovascular therapies and developing new treatment strategies. The objective of this article is to provide a review of clinical and experimental animal studies on the histology, imaging correlation, and ultrastructure of thromboemboli retrieved during acute ischemic stroke.
Get full access to this article
View all available purchase options and get full access to this article.
REFERENCES
1.
Williams GR, Jiang JG, Matchar DB, Samsa GP. Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke 1999;30:2523–2528.
2.
American Heart Association. Heart and Stroke Facts 2003. Available at: www.americanheart.org/downloadable/heart/1056719919740HSFacts2003text.pdf. Accessed July 29, 2005.
3.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.
4.
Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3–5 hours after symptom onset: the ATLANTIS study: a randomized controlled trial: alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 1999;282:2019–2026.
5.
Adams HP, Adams RJ, Brott T, et al. Stroke Council of the American Stroke Association: guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056–1083.
6.
Nogueira RG, Schwamm LH, Hirsch JA. Endovascular approaches to acute stroke, part 1: drugs, devices, and data. AJNR Am J Neuroradiol 2009;30:649–661.
7.
Torvik A, Jorgensen L. Thrombotic and embolic occlusions of the carotid arteries in an autopsy material, part I: prevalence, location and associated diseases. J Neurol Sci 1964;1:24–39.
8.
Gobin YP, Starkman S, Duckwiler GR, et al. MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004;35:2848–2854.
9.
Smith WS, Sung G, Starkman S, et al. MERCI Trial Investigators: safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI Trial. Stroke 2005;36:1432–1440.
10.
Felten RP, Ogden NRP, Pena C, Provost MC, Schlosser MJ, Witten CM. The Food and Drug Administration medical device review process: clearance of a clot retriever for use in ischemic stroke. Stroke 2005;36:404–406.
11.
Molina C, Saver JL. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacologic, mechanical, and imaging strategies. Stroke 2005;36:2311–2320.
12.
Marder VJ, Chute DJ, Starkman S, et al. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 2006;37:2086–2093.
13.
Williams DO, Borer J, Braunwald E, et al. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. Circulation 1986;73:338–346.
14.
Chaves CJ, Caplan LR. Heparin and oral anticoagulants in the treatment of brain ischemia. J Neurol Sci 2000;173:3–9.
15.
Kim YS, Garami Z, Mikulik R, Molina CA, Alexandrov AV. CLOTBUST Collaborators: early recanalization rates and clinical outcomes in patients with tandem internal carotid artery/middle cerebral artery occlusion and isolated middle cerebral artery occlusion. Stroke 2005;36:869–871.
16.
Oliveira-Filho J, Massaro AR, Yamamoto F, Bustamante L, Scaff M. Stroke as the first manifestation of calcific aortic stenosis. Cerebrovasc Dis 2000;10:413–416.
17.
Spuentrup E, Botnar RM, Wiethoff AJ, et al. MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients. Eur Radiol 2008;18:1995–2005.
18.
Uppal R, Catana C, Ay I, Benner T, Sorensen AG, Caravan P. Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe: feasibility study in rat model. Radiology 2011;258:812–820.
19.
Gacs G, Fox AJ, Barnett HJM, Vinuela F. CT visualization of intracranial arterial thromboembolism. Stroke 1983;14:756–762.
20.
Manelfe C, Larrue V, von Kummer R, et al. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke 1999;30:769–772.
21.
Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ. rt-PA Acute Stroke Study Group. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 1993;14:3–13.
22.
Liebeskind DS, Sanossian N, Yong WH, et al. CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke 2011;42:1237–1240.
23.
Nogueira RG, Sukavaneshvar S, Rabinov JD, et al. Scanning electron microscopy analysis of thromboembolic material retrieved from cerebral and cervical arteries of patients with acute ischemic stroke. Presented at the International Stroke Conference; 2008.
24.
Jang IK, Gold HK, Ziskind AA, et al. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator: a possible explanation for resistance to coronary thrombolysis. Circulation 1989;79: 920.
25.
Kirchhof K, Sikinger M, Welzel T, Zoubaa S, Sartor K. Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus? Rofo 2004;176:98–105.
26.
Niessen F, Hilger T, Hoehn M, Hossmann KA. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke. Stroke 2003;34:2019–2024.
Information & Authors
Information
Published In
Copyright
Copyright © 2012 by AAN Enterprises, Inc.
Publication History
Received: June 28, 2011
Accepted: October 26, 2011
Published online: September 24, 2012
Published in print: September 25, 2012
Disclosure
Dr. Mehta reports no disclosures. Dr. Nogueira has served on a scientific advisory board or data safety monitoring board for Concentric Medical, Inc; ev3 Neurovascular, Inc.; Coaxia; NeuroInterventional Therapeutics, Inc.; Rapid Medical; and Reverse Medical; and performs thrombectomy for acute ischemic stroke. Go to Neurology.org for full disclosures.
Authors
Author Contributions
Dr. Mehta: drafting/revising the manuscript, analysis or interpretation of data. Dr. Nogueira: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, acquisition of data, study supervision.
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Factors influencing the efficacy of recombinant tissue plasminogen activator: Implications for ischemic stroke treatment, PLOS ONE, 19, 6, (e0302269), (2024).https://doi.org/10.1371/journal.pone.0302269
- Multimaterial decomposition in dual-energy CT for characterization of clots from acute ischemic stroke patients, European Radiology Experimental, 8, 1, (2024).https://doi.org/10.1186/s41747-024-00443-3
- Endovascular Therapy for Acute Ischemic Stroke, Ischemic Stroke Therapeutics, (69-82), (2024).https://doi.org/10.1007/978-3-031-49963-0_5
- “Time lost is clot resolution lost”: the neglected perspective of the therapeutic time window for ischemic stroke, Frontiers in Neurology, 14, (2023).https://doi.org/10.3389/fneur.2023.1177609
- Leukocytes in Cerebral Thrombus Respond to Large-Vessel Occlusion in a Time-Dependent Manner and the Association of NETs With Collateral Flow, Frontiers in Immunology, 13, (2022).https://doi.org/10.3389/fimmu.2022.834562
- Non contrast enhanced volumetric histology of blood clots through high resolution propagation-based X-ray microtomography, Scientific Reports, 12, 1, (2022).https://doi.org/10.1038/s41598-022-06623-8
- Calcified cerebral embolism: a 9-case series and review of the literature, Neurología (English Edition), 37, 6, (421-427), (2022).https://doi.org/10.1016/j.nrleng.2019.04.002
- Embolia cerebral cálcica: presentación de una serie de 9 casos y revisión de la literatura, Neurología, 37, 6, (421-427), (2022).https://doi.org/10.1016/j.nrl.2019.04.004
- Development and Testing of Thrombolytics in Stroke, Journal of Stroke, 23, 1, (12-36), (2021).https://doi.org/10.5853/jos.2020.03349
- Heterogeneity between proximal and distal aspects of occlusive thrombi on pretreatment imaging in acute ischemic stroke, The Neuroradiology Journal, 35, 3, (378-387), (2021).https://doi.org/10.1177/19714009211049713
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.